The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
Open accessAbstract
Hepatitis C virus (HCV) is a major cause of chronic hepatitis. The virus does not replicate efficiently in cell cultures, and it is therefore difficult to assess infection-neutralizing antibodies and to evaluate protective immunity in vitro. To study the binding of the HCV envelope to cell-surface receptors, we developed an assay to assess specific binding of recombinant envelope proteins to human cells and neutralization thereof. HCV recombinant envelope proteins expressed in various systems were incubated with human cells, and binding was assessed by flow cytometry using anti-envelope antibodies. Envelope glycoprotein 2 (E2) expressed in mammalian cells, but not in yeast or insect cells, binds human cells with high affinity (Kd approximately 10(-8) M). We then assessed antibodies able to neutralize E2 binding in the sera of both vaccinated and carrier chimpanzees, as well as in the sera of humans infected with various HCV genotypes. Vaccination with recombinant envelope proteins expressed in mammalian cells elicited high titers of neutralizing antibodies that correlated with protection from HCV challenge. HCV infection does not elicit neutralizing antibodies in most chimpanzees and humans, although low titers of neutralizing antibodies were detectable in a minority of infections. The ability to neutralize binding of E2 derived from the HCV-1 genotype was equally distributed among sera from patients infected with HCV genotypes 1, 2, and 3, demonstrating that binding of E2 is partly independent of E2 hypervariable regions. However, a mouse monoclonal antibody raised against the E2 hypervariable region 1 can partially neutralize binding of E2, indicating that at least two neutralizing epitopes, one of which is hypervariable, should exist on the E2 protein. The neutralization-of-binding assay described will be useful to study protective immunity to HCV infection and for vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic organization and diversity of the hepatitis C virus.
Choo, Q. L., Richman, K. H., Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, R., & Barr, P. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2451 · Cited by 1,716
Self-citationThe Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Weiner, A. J., Geysen, H. M., Christopherson, C., Hall, J. E., Mason, T. J., Saracco, G., Bonino, F., Crawford, K., Marion, C. D., & Crawford, K. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3468 · Cited by 704
Self-citationVaccination of chimpanzees against infection by thehepatitis C virus.
Choo, Q. L., Kuo, G., Ralston, R., Weiner, A., Chien, D., Van Nest, G., Han, J., Berger, K., Thudium, K., & Kuo, C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1294 · Cited by 575
Self-citationFarci, P., Alter, H. J., Wong, D. C., Miller, R. H., Govindarajan, S., Engle, R., Shapiro, M., & Purcell, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7792 · Cited by 486
Shimizu, Y. K., Hijikata, M., Iwamoto, A., Alter, H. J., Purcell, R. H., & Yoshikura, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1494-1500.1994 · Cited by 405
T-lymphocyte response to hepatitis C virus in different clinical courses of infection
Botarelli, P., Brunetto, M. R., Minutello, M. A., Calvo, P., Unutmaz, D., Weiner, A. J., Choo, Q.-L., Shuster, J. R., Kuo, G., Bonino, F., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90430-k · Cited by 313
Self-citationHepatitis C virus six years on
van der Poel, C. L., Reesink, H. W., & Cuypers, H. T. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90293-3 · Cited by 201
Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells
Spaete, R. R., Alexander, D., Rugroden, M. E., Choo, Q., Berger, K., Crawford, K., Kuo, C., Leng, S., Lee, C., Ralston, R., et al. (1992) · Virology · doi:10.1016/0042-6822(92)90537-y · Cited by 120
Self-citationChien, D. Y., Choo, Q. L., Tabrizi, A., Kuo, C., McFarland, J., Berger, K., Lee, C., Shuster, J. R., Nguyen, T. T., & Moyer, D. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10011 · Cited by 118
Self-citation
Cited by
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Self-citationReplication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J., Balestrieri, A., et al. (2000) · Science · doi:10.1126/science.288.5464.339 · Cited by 884
Self-citationAlter, H. J., & Seeff, L. B. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9505 · Cited by 736
Rappuoli, R. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00119-3 · Cited by 704
Replication of hepatitis C virus
Bartenschlager, R., & Lohmann, V. (2000) · Microbiology · doi:10.1099/0022-1317-81-7-1631 · Cited by 611
Farci, P., Shimoda, A., Wong, D., Cabezon, T., De Gioannis, D., Strazzera, A., Shimizu, Y., Shapiro, M., Alter, H. J., & Purcell, R. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15394 · Cited by 603
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Law, M., Maruyama, T., Lewis, J., Giang, E., Tarr, A. W., Stamataki, Z., Gastaminza, P., Chisari, F. V., Jones, I. M., Fox, R. I., et al. (2008) · Nature Medicine · doi:10.1038/nm1698 · Cited by 591
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate
Barth, H., Schäfer, C., Adah, M. I., Zhang, F., Linhardt, R. J., Toyoda, H., Kinoshita-Toyoda, A., Toida, T., van Kuppevelt, T. H., Depla, E., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302267200 · Cited by 500
Flint, M., Maidens, C., Loomis-Price, L. D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S., & McKeating, J. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6235-6244.1999 · Cited by 469
Neutralizing antibody response during acute and chronic hepatitis C virus infection
Logvinoff, C., Major, M. E., Oldach, D., Heyward, S., Talal, A., Balfe, P., Feinstone, S. M., Alter, H., Rice, C. M., & McKeating, J. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403519101 · Cited by 433
Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
Cerny, A., & Chisari, F. V. (1999) · Hepatology · doi:10.1002/hep.510300312 · Cited by 410
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
Pöhlmann, S., Zhang, J., Baribaud, F., Chen, Z., Leslie, G. J., Lin, G., Granelli-Piperno, A., Doms, R. W., Rice, C. M., & McKeating, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4070-4080.2003 · Cited by 389
The Hepatitis C Virus Life Cycle as a Target for New Antiviral Therapies
Pawlotsky, J., Chevaliez, S., & McHutchison, J. G. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.116 · Cited by 325
Prospects for a vaccine against the hepatitis C virus
Houghton, M., & Abrignani, S. (2005) · Nature · doi:10.1038/nature04081 · Cited by 312
Self-citationNovel Insights into Hepatitis C Virus Replication and Persistence
Bartenschlager, R., Frese, M., & Pietschmann, T. (2004) · Advances in Virus Research · doi:10.1016/s0065-3527(04)63002-8 · Cited by 307
Applications of flow cytometry to clinical microbiology
Álvarez-Barrientos, A., Arroyo, J., Cantón, R., Nombela, C., & Sánchez-Pérez, M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.167 · Cited by 300
“This method permits study of the natural immunity to HCV and should be useful in the development and validation of vaccination protocols.”
MethodInfluentialOwsianka, A., Tarr, A. W., Juttla, V. S., Lavillette, D., Bartosch, B., Cosset, F.-L., Ball, J. K., & Patel, A. H. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11095-11104.2005 · Cited by 289
CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs
Kitadokoro, K. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.12 · Cited by 282
Rosa, D., Saletti, G., De Gregorio, E., Zorat, F., Comar, C., D'Oro, U., Nuti, S., Houghton, M., Barnaba, V., Pozzato, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509402102 · Cited by 278
Self-citation
Metadata
- Authors
- Rosa, D., Campagnoli, S., Moretto, C., Guenzi, E., Cousens, L., Chin, M., Dong, C., Weiner, A. J., Lau, J. Y., Choo, Q. L., Chien, D., Pileri, P., Houghton, M., & Abrignani, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-03-05
- Volume
- 93
- Issue
- 5
- Pages
- 1759-1763
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2132341678
- Cited by
- 344
- References
- 10
- FWCI
- 17.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.